153 related articles for article (PubMed ID: 20198185)
1. A docking model of human ribonucleotide reductase with flavin and phenosafranine.
Priya PL; Shanmughavel P
Bioinformation; 2009 Sep; 4(3):123-6. PubMed ID: 20198185
[TBL] [Abstract][Full Text] [Related]
2. Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase.
Iman M; Khansefid Z; Davood A
Recent Pat Anticancer Drug Discov; 2016; 11(4):461-468. PubMed ID: 27670694
[TBL] [Abstract][Full Text] [Related]
3. Structure, function, and mechanism of ribonucleotide reductases.
Kolberg M; Strand KR; Graff P; Andersson KK
Biochim Biophys Acta; 2004 Jun; 1699(1-2):1-34. PubMed ID: 15158709
[TBL] [Abstract][Full Text] [Related]
4. Ribonucleotide reductase: Implications of thiol S-nitrosylation and tyrosine nitration for different subunits.
Chakraborty S; Mukherjee P; Sengupta R
Nitric Oxide; 2022 Oct; 127():26-43. PubMed ID: 35850377
[TBL] [Abstract][Full Text] [Related]
5. Metal-free ribonucleotide reduction powered by a DOPA radical in Mycoplasma pathogens.
Srinivas V; Lebrette H; Lundin D; Kutin Y; Sahlin M; Lerche M; Eirich J; Branca RMM; Cox N; Sjöberg BM; Högbom M
Nature; 2018 Nov; 563(7731):416-420. PubMed ID: 30429545
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.
Popović-Bijelić A; Kowol CR; Lind ME; Luo J; Himo F; Enyedy EA; Arion VB; Gräslund A
J Inorg Biochem; 2011 Nov; 105(11):1422-31. PubMed ID: 21955844
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic studies of the iron and manganese reconstituted tyrosyl radical in Bacillus cereus ribonucleotide reductase R2 protein.
Tomter AB; Zoppellaro G; Bell CB; Barra AL; Andersen NH; Solomon EI; Andersson KK
PLoS One; 2012; 7(3):e33436. PubMed ID: 22432022
[TBL] [Abstract][Full Text] [Related]
8. Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs.
Plamthottam S; Sun D; Van Valkenburgh J; Valenzuela J; Ruehle B; Steele D; Poddar S; Marshalik M; Hernandez S; Radu CG; Zink JI
J Biol Inorg Chem; 2019 Aug; 24(5):621-632. PubMed ID: 31250199
[TBL] [Abstract][Full Text] [Related]
9. Detection of a new substrate-derived radical during inactivation of ribonucleotide reductase from Escherichia coli by gemcitabine 5'-diphosphate.
van der Donk WA; Yu G; Pérez L; Sanchez RJ; Stubbe J; Samano V; Robins MJ
Biochemistry; 1998 May; 37(18):6419-26. PubMed ID: 9572859
[TBL] [Abstract][Full Text] [Related]
10. Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly.
Xu H; Faber C; Uchiki T; Racca J; Dealwis C
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4028-33. PubMed ID: 16537480
[TBL] [Abstract][Full Text] [Related]
11. The tyrosyl free radical in ribonucleotide reductase.
Gräslund A; Sahlin M; Sjöberg BM
Environ Health Perspect; 1985 Dec; 64():139-49. PubMed ID: 3007085
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase inhibitors and future drug design.
Shao J; Zhou B; Chu B; Yen Y
Curr Cancer Drug Targets; 2006 Aug; 6(5):409-31. PubMed ID: 16918309
[TBL] [Abstract][Full Text] [Related]
13. The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass.
Högbom M; Stenmark P; Voevodskaya N; McClarty G; Gräslund A; Nordlund P
Science; 2004 Jul; 305(5681):245-8. PubMed ID: 15247479
[TBL] [Abstract][Full Text] [Related]
14. A stable FeIII-FeIV replacement of tyrosyl radical in a class I ribonucleotide reductase.
Voevodskaya N; Lendzian F; Gräslund A
Biochem Biophys Res Commun; 2005 May; 330(4):1213-6. PubMed ID: 15823572
[TBL] [Abstract][Full Text] [Related]
15. Rnr4p, a novel ribonucleotide reductase small-subunit protein.
Wang PJ; Chabes A; Casagrande R; Tian XC; Thelander L; Huffaker TC
Mol Cell Biol; 1997 Oct; 17(10):6114-21. PubMed ID: 9315671
[TBL] [Abstract][Full Text] [Related]
16. EPR studies on a stable sulfinyl radical observed in the iron-oxygen-reconstituted Y177F/I263C protein R2 double mutant of ribonucleotide reductase from mouse.
Adrait A; Ohrström M; Barra AL; Thelander L; Gräslund A
Biochemistry; 2002 May; 41(20):6510-6. PubMed ID: 12009915
[TBL] [Abstract][Full Text] [Related]
17. Cotransport of the heterodimeric small subunit of the Saccharomyces cerevisiae ribonucleotide reductase between the nucleus and the cytoplasm.
An X; Zhang Z; Yang K; Huang M
Genetics; 2006 May; 173(1):63-73. PubMed ID: 16489218
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus sanguinis class Ib ribonucleotide reductase: high activity with both iron and manganese cofactors and structural insights.
Makhlynets O; Boal AK; Rhodes DV; Kitten T; Rosenzweig AC; Stubbe J
J Biol Chem; 2014 Feb; 289(9):6259-72. PubMed ID: 24381172
[TBL] [Abstract][Full Text] [Related]
19. Development of ribonucleotide reductase inhibitors: a review on structure activity relationships.
Moorthy NS; Cerqueira NM; Ramos MJ; Fernandes PA
Mini Rev Med Chem; 2013 Nov; 13(13):1862-72. PubMed ID: 24032510
[TBL] [Abstract][Full Text] [Related]
20. A new tyrosyl radical on Phe208 as ligand to the diiron center in Escherichia coli ribonucleotide reductase, mutant R2-Y122H. Combined x-ray diffraction and EPR/ENDOR studies.
Kolberg M; Logan DT; Bleifuss G; Pötsch S; Sjöberg BM; Gräslund A; Lubitz W; Lassmann G; Lendzian F
J Biol Chem; 2005 Mar; 280(12):11233-46. PubMed ID: 15634667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
